405 results
Page 2 of 21
S-8
EX-4.4
zognvi
22 Feb 24
Registration of securities for employees
5:50pm
424B5
i1a bzx2dt7
21 Feb 24
Prospectus supplement for primary offering
8:39am
8-K
EX-99.1
cmgcrjr3lw4k
2 Feb 24
AbbVie Reports Full-Year and Fourth-Quarter 2023 Financial Results
7:51am
8-K
4dw8jz 4z4
5 Jan 24
Guidance Including the Impact of Acquired IPR&D and Milestones Expense
4:03pm
8-K
EX-99.1
en9g4mzd59l5j6
27 Oct 23
AbbVie Reports Third-Quarter 2023 Financial Results
7:49am
8-K
tsr2tgcf4gfnvtiljm
4 Oct 23
Guidance Including the Impact of Acquired IPR&D and Milestones Expense
4:11pm
8-K
EX-99.1
5lmd7 hq3l
27 Jul 23
AbbVie Reports Second-Quarter 2023 Financial Results
7:45am
8-K
q5td 9jp1lnawma9
6 Jul 23
Guidance Including the Impact of Acquired IPR&D and Milestones Expense
4:18pm
11-K
4nfk2nl9
28 Jun 23
Annual report of employee stock purchases
5:00pm